IMPORTANT INFORMATION

Access to the information and documents on this portion of the website is restricted for regulatory reasons. You are requested to review the following information and make the following confirmation each time you seek to access this restricted information. Your confirmation must be true and accurate.

Please enter your country of residence:

IMPORTANT INFORMATION

ACCESS TO THE INFORMATION AND DOCUMENTS ON THIS PORTION OF THE WEBSITE IS RESTRICTED FOR REGULATORY REASONS. YOU ARE REQUESTED TO REVIEW THE FOLLOWING INFORMATION AND MAKE THE FOLLOWING CONFIRMATION EACH TIME YOU SEEK TO ACCESS THIS RESTRICTED INFORMATION. YOUR CONFIRMATION MUST BE TRUE AND ACCURATE.

ELECTRONIC VERSIONS OF THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE ON THIS WEBSITE BY DARKTRACE PLC (THE "ISSUER") IN GOOD FAITH AND ARE FOR INFORMATION PURPOSES ONLY. THE ISSUER DOES NOT ACCEPT ANY RESPONSIBILITY FOR ANY CONTRAVENTION OF APPLICABLE SECURITIES LAWS AND REGULATIONS BY INDIVIDUALS FOR THE ACCURACY, COMPLETENESS OR FAIRNESS OR USE OF INFORMATION PROVIDED BY SUCH INDIVIDUALS.

THESE MATERIALS ARE NOT DIRECTED AT OR ACCESSIBLE BY PERSONS IN THE UNITED STATES OR PERSONS RESIDENT OR LOCATED IN AUSTRALIA, CANADA, DUBAI, HONG KONG, JAPAN, SINGAPORE, SWITZERLAND OR ANY OTHER JURISDICTION WHERE THE EXTENSION OF AVAILABILITY OF THE MATERIALS TO WHICH YOU ARE SEEKING ACCESS WOULD BREACH ANY APPLICABLE LAW OR REGULATION.

The release, publication or distribution of the documents or other information contained herein may be restricted by law in certain jurisdictions. Persons into whose possession any of the documents or other information contained herein come should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws or regulations of such jurisdiction.

The information and documents on this portion of the website (a) are intended only for, and may be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to (i) "qualified institutional buyers" (as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the "US Securities Act") ("QIBs") or (ii) persons resident or physically present outside the United States (including its territories and possessions, any state of the United States and the District of Columbia), Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland and resident and physically present in a jurisdiction in which such access, distribution or dissemination would not constitute a violation of the local securities laws or regulations of such jurisdiction, and (b) are not and do not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Issuer in the United States, Australia, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction in which such offer or solicitation would constitute a violation of the local securities laws or regulations of such jurisdiction or would be otherwise unlawful.

Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the US Securities Act. In particular, the securities have not been and will not be registered under the US Securities Act, and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act. Any securities will not be registered under or offered in compliance with applicable securities laws of any state, province, territory, county or jurisdiction of the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland. Accordingly, unless an exemption under the relevant securities law is applicable, any such securities may not be offered, sold, resold, delivered or distributed, directly or indirectly, in or into the United States, Canada, Dubai, Hong Kong, Japan, Singapore, Switzerland or any other jurisdiction if to do so would constitute a violation of the relevant laws of, or require registration thereof in, such jurisdiction. There will be no public offering of securities in the United States. Any securities sold in the United States will be sold only to QIBs in reliance on an exemption from, or transaction not subject to, the registration requirements of the US Securities Act.

The information and documents on this portion of the website are being addressed to and directed at persons in member states of the European Economic Area ("Member States") who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation (Regulation (EU) 2017/1129), as amended by The Prospectus (Amendment etc.) (EU Exit) Regulations 2019, and which is part of UK law by virtue of the European Union (Withdrawal) Act 2018 who are also persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 as amended (the "Order") or who are high net worth bodies corporate, unincorporated associations and partnerships or the trustee of high value trusts falling within Article 49(2)(a) to (d) of the Order, and other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this document relates is available only to Relevant Persons in the United Kingdom and Qualified Investors in Member States, and will only be engaged with such persons. Persons who are not Relevant Persons (in the United Kingdom) or Qualified Investors (in Member States) should not act or rely on this document or any of its contents..

Certain statements contained in documents available on this part of the website constitute forward-looking statements. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in documents available on this part of the website that reference past trends or activities should not be taken as a representation that such trends or activities will necessarily continue in the future. You should not place undue reliance on forward-looking statements, which speak only as of the date of the relevant document.

To confirm that:

you have read, understand and agree to comply with all of the restrictions set forth above;
you are either (i) a QIB in the United States or (ii) are resident and physically present in a country outside the United States, Canada, Dubai, Hong Kong, Japan, Singapore or Switzerland or any other jurisdiction in which such distribution or access is unlawful;
you are not resident or physically present in any Member State, unless you are a Qualified Investor;
you are not resident or physically present in the United Kingdom, unless you are a Relevant Person;
it is lawful for you to review and receive copies of the documents on this website;
you agree that you will not transmit or otherwise send any information contained in this website to any person in the United States or to publications with a general circulation in the United States; and
are authorised and permitted to proceed to electronic versions of the information and documents on this portion of the website.

Please select "I confirm" below:

DISCLAIMER – IMPORTANT

We regret that, due to applicable legal restrictions, we are unable to provide you with access to this section of our website.

We apologise for any inconvenience this may cause.

Click here to return to the homepage.

Regulatory News

Q1 FY 2023 Trading Update

RNS Number : 5614C

Darktrace PLC

12 October 2022

12^th October 2022

Darktrace plc Q1 FY 2023 Trading Update

Continuing sales momentum drives Q1 performance, confirmation of FY 2023 expectations

Darktrace plc (DARK.L) (together with its subsidiaries, "Darktrace" or the "Group") a global leader in cyber security AI, today provides a trading update for its first quarter FY 2023 ended 30^th September 2022.

Operating and Financial Performance

For Q1 FY 2023, Darktrace demonstrated continuing strength and resilience in its sales performance, growing its customer base by 320 net new customers to 7,757, a 29.1% year-over-year increase.

With new customer additions continuing to be the primary driver of constant currency Annual Recurring Revenue (ARR) measures, this resulted in net ARR added for Q1 FY 2023 of $26.6m, up 13.4% over the same quarter of FY 2022. This was in line with Darktrace's expectations for first quarter net ARR additions, in what is traditionally its slowest sales quarter of the year. The net ARR added during the first quarter, on top of strong performance in recent periods, resulted in constant currency ARR at 30^th September 2022 of $511.5 million, reflecting year-over-year growth of 40.5%.

Considering the recent foreign exchange ("FX") rate environment, Darktrace is now also reporting USD ARR to provide context for its revenue reporting and expectations, which are provided in U.S Dollars ("USD"). Darktrace's USD ARR at 30^th September 2022 was $494.4 million, highlighting that, particularly late in the first quarter, exchange rate movements created a $17.1 million headwind that is likely to impact the conversion of constant currency ARR to USD revenue for the rest of FY 2023.

Revenue for Q1 FY 2023 was $126.3 million, up 37.0% over the same quarter of FY 2022. Had foreign exchange rates remained at the rates in effect on 30^th June 2022 (the Group's FY 2023 constant currency rates), Darktrace's revenue would have been $126.1 million. As would be expected, recent exchange rate movements had a limited impact on Q1 FY 2023 revenue. This is because FX rates used to recognise revenue are set at the point of invoicing and most revenue recognised in the first quarter was invoiced either prior to, or early in, the quarter. This headwind is likely to have an increasing impact on future reporting periods, as recent and upcoming invoicing begins to contribute a greater proportion of Darktrace's FY 2023 revenue.

Gross margin, as well as one-year gross ARR churn and net ARR retention rates, remained in the ranges reported in our most recent period.

FY 2023 Outlook

Darktrace last communicated its expectations for the current financial year on 8^th September 2022, with its FY 2022 earnings release. In the intervening period, September results were as expected, so it is pleased to reiterate the FY 2023 guidance and related commentary it previously provided for ARR, net ARR added, revenue, adjusted EBITDA, and free cash flow margin. Darktrace is also reconfirming its expectations for the seasonality of net ARR added for the financial year but is updating its seasonality expectation for revenue to reflect recent developments in the FX rate markets.

Though the U.S. Dollar continues to be unusually strong relative to Darktrace's other operating currencies, its key FX rates have recovered somewhat from the lows experienced in late September. On this basis, Darktrace is maintaining its expectation for FY 2023 year-over-year revenue growth of between 30% and 33%, though it will continue to monitor FX rates, and their potential impacts on revenue, for downside movement relative to rates at this reporting date. To reflect that future FY 2023 revenues are likely to experience increasing drag from FX rate impacts, however, Darktrace now expects that 46% to 47% of its revenue will be recognised in the first half of FY 2023 (previously 45% to 46%).

Cathy Graham, CFO of Darktrace, said:

"Using our market-leading Self-Learning AI technology, Darktrace empowers organisations to interrupt cyber threats before they experience a business disruption. This focus, and the value it provides to users of our technology, allowed us to maintain strong sales activity through the first quarter of FY 2023, again expanding our customer base, ARR and revenue.

We expect this momentum to be further supported across the rest of this financial year as we complete the phased roll-out of our new PREVENT product family. These products started to be made available to existing and new customers in mid-first quarter, and in September drove a significant increase in upsell proof of value ("POV") deployments within our customer base. We believe that PREVENT product sales should start making positive contributions to our ARR growth and net retention measures in the second half of FY 2023."

About Darktrace

Darktrace (DARK:L), a global leader in cyber security artificial intelligence is on a mission to free the world of cyber disruption. Breakthrough innovations in the Darktrace Cyber AI Research Centre in Cambridge, UK have resulted in over 115 patent applications filed and research published to contribute to the cyber security community. Rather than study attacks, Darktrace's technology continuously learns and updates its knowledge of 'you' and applies that understanding to optimise your state of optimal cyber security. Darktrace is delivering the first ever Cyber AI Loop, fuelling a continuous end-to-end security capability that can autonomously spot and respond to novel in-progress threats within seconds. Darktrace employs over 2,100 people around the world and protects over 7,700 customers globally from advanced cyber threats. Darktrace was named one of TIME magazine's 'Most Influential Companies' in 2021.

Cautionary Statement

This announcement contains certain forward-looking statements, including with respect to the Group's current targets, expectations and projections about future performance, anticipated events or trends and other matters that are not historical facts. These forward-looking statements, which sometimes use words such as "aim", "anticipate", "believe", "intend", "plan", "estimate", "expect" and words of similar meaning, include all matters that are not historical facts and reflect the directors' beliefs and expectations, made in good faith and based on the information available to them at the time of the announcement. Such statements involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement and should be treated with caution. Any forward-looking statements made in this announcement by or on behalf of Darktrace speak only as of the date they are made. Except as required by applicable law or regulation, Darktrace expressly disclaims any obligation or undertaking to publish any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in its expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based.

Enquiries:

Luk Janssens - Head of Investor Relations, Darktrace

Direct: +44 7811 027918

[email protected]

Powerscourt (Public Relations adviser to Darktrace)

Victoria Palmer-Moore/Elly Williamson

Direct +44 (0) 20 3328 9386

[email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTEAAEFFLEAFAA

TR-1: Notification of major holdings ›

Director/PDMR Shareholding ›

Back to:

Back to Regulatory News ⌃

Q1 FY 2023 Trading Update

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal

Products

Core Coverage

AI Research Centre

Company

Partners

Legal